Pharvaris is advancing deucrictibant, an oral bradykinin B2-receptor antagonist, in two late-stage trials. Read my analysis ...

Imagine a future where artificial intelligence quietly shoulders the drudgery of software development: refactoring tangled ...

Lyell Immunopharma's LYL314 CAR-T therapy shows durable responses in advanced LBCL patients. Learn about trials and upcoming ...

Skeena Resources Limited (TSX: SKE, NYSE: SKE) ('Skeena Gold & Silver”, 'Skeena” or the 'Company”) reports that it has filed ...

(TSX: BTO, NYSE AMERICAN: BTG, NSX: B2G) (“B2Gold” or the “Company”) is pleased to announce the positive results of a Feasibility Study (“FS”) on its 100% owned Gramalote gold project located in the ...

In this valuable study, the authors provide a simple yet elegant approach to identifying therapeutic targets that synergize to prevent therapeutic resistance in ovarian cancer using cell lines, ...

Characterization of intracellular synapse heterogeneity aides to understand the intricate computational logic of neuronal circuits. Despite recent advances in connectomics, the spatial patterns of ...

June’s job losses pushed the region’s unemployment rate to 7.2 per cent, up from May’s 6.9 per cent – the second highest ...

Amid the extreme volatility in today’s markets, quant investors are leveraging artificial intelligence (AI) to enhance decision-making at the margins, rather than fully replacing traditional ...

Jewish philanthropy in America has been driven by the religious imperative known as “tikkun olam”—that is, to repair the ...